# Levothyroxine Sodium

NDC: 42023-201
Generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Labeler / Manufacturer: ENDO USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110624

FDA application: NDA202231

## Active ingredients

- LEVOTHYROXINE SODIUM ANHYDROUS: 100 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d815416-11c9-470e-a82f-89b0bf232e12